why choose us

Clinical Trials Search

Showing 7,050 of 132,085 result(s)
Enhancing Strength Gains With the Power of the Mind

Status: Completed

Condition: Healthy

Interventions: This training intervention will be 6 weeks of moderate-intensity elastic band training, including whole-body and isolated muscle exercises.

Date: 2023-10-19

Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis

Status: Completed

Condition: Atopic Dermatitis

Interventions: Monoclonal Antibody

Date: 2023-10-19

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Status: Completed

Condition: Esophageal Cancer

Interventions: Stereotactic ablative radiotherapy (SABR) or interventional radiology (IR) ablation therapy

Date: 2023-10-19

A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis

Status: Completed

Condition: Seborrheic Keratosis

Interventions: SM-020 gel 1.0% will be applied topically.
Subjects will be treated with twice daily application to 5 to 10 SKTLs for approximately 28 days.

Date: 2023-10-19

Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy

Status: NOT_YET_RECRUITING

Condition: Plantar Fascitis

Interventions:

Participants will receive a home exercise program that consists of 2 exercises and 3 stretches.
The exercises include:

  • Massage on t

    Date: 2023-10-19

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)

Status: Completed

Condition: Dermatosis Papulosa Nigra

Interventions: Subjects will apply the investigational product twice daily for 4 consecutive weeks.
Subjects will be followed for 12 weeks post final applicatio

Date: 2023-10-19

CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)

Status: NOT_YET_RECRUITING

Condition: Pancreas Cancer

Interventions: Capecitabine is an oral prodrug that is enzymatically converted to 5-fluorouracil (5-FU) in vivo.
Both normal and tumor cells metabolize 5-FU to

Date: 2023-10-19

SIBTime Phase II: Web Application for Typically Developing Siblings

Status: Completed

Condition: Early Life Stress

Interventions: Parent-child dyads will use the SIBTime app in an 8-week intervention to test its relevance, acceptability, cultural appropriateness, and potential fo

Date: 2023-10-19

Skin Change Actions by Nursing

Status: Completed

Condition: Pressure Injury

Interventions: Implementation of the SEM Scanner as part of weekly standard skin assessments of sacrum and heels

Date: 2023-10-19

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Status: Completed

Condition: Prostate Cancer

Interventions: Stereotactic ablative radiotherapy (SABR) or interventional radiology (IR) ablation therapy

Date: 2023-10-19